Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 29, Issue 3
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Research methods and reporting
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
Online download statistics by month:
Online download statistics by month: October 2023 to August 2024
Abstract
Full
Pdf
Oct 2023
1502
19
10
Nov 2023
1398
775
64
Dec 2023
342
341
54
Jan 2024
363
350
67
Feb 2024
140
139
37
Mar 2024
1631
1631
72
Apr 2024
144
139
25
May 2024
188
190
41
Jun 2024
166
155
47
Jul 2024
185
180
58
Aug 2024
100
101
68
Total
6159
4020
543
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF